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doi:10.1016/j.ejvs.2010.01.021Abstract Objectives: We report a new salvage technique for treating venous aneurysms (VAs)
complicating vascular access arteriovenous fistula (AVF) using externally reinforced venous
aneurysmorrhaphy.
Design: A retrospective study over a 20-month period from a single centre.
Patients: Patients presenting to the vascular surgery department, Bordeaux University
Hospital for revision of a vascular access AVF were included.
Methods: Reinforced venous aneurysmorraphy consisted in removal of redundant vessel wall
followed by reinforcement using an external prosthetic graft. Patency, diameter and flow were
assessed by duplex ultrasound at 1, 6 and 12 months after salvage.
Results: Thirty-eight eligible patients were identified. Five were excluded because VA was
associated with central vein stenosis; the remaining 33 underwent salvage. Indications were
rapidly expanding or painful VA in seven cases; VA with frequent bleeding or damaged overlying
skin in eight; VA in close relation to a stenosis in two; and VA associated with high-flow rate in
16. Cannulation was attempted after 30 days. Mean follow-up time was 12 S.D. 5 months
(range: 4e22). Two repaired AVFs failed. Primary 1-year patency was 93%. No aneurysm or
infection occurred. Reduction of high flow was successful in 12 of 16 patients. The remaining
four required re-operation.Chirurgie Vasculaire, Hoˆpital Pellegrin, CHU Bordeaux, Place Ame´lie Raba Le´on, 33000 Bordeaux,
þ33 (0) 556796105.
-bordeaux.fr (X. Berard).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
New Treatment for Aneurysmal Arteriovenous Fistula 101Conclusions: Reinforced venous aneurysmorrhaphy is effective in controlling venous dilation
and achieving patency. Reduction of high-flow rates was not always achieved. Further study
is needed to evaluate long-term efficacy of this treatment.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Figure 1 Dissection of the aneurysmal arterialised vein using
staged skin incisions.Introduction
Problems arising from haemodialysis vascular access account
for more than 20% of hospitalisations involving patients with
end-stage renal failure,1 a steadily growing population
worldwide.2 The main causes of these problems are stenosis,
thrombosis and steal syndrome. However, venous aneurysm
(VA) complicating arteriovenous fistula (AVF) has probably
been underreported in the literature. The potential severity
of VA is high due to the risk of rupture and possibly fatal
haemorrhage.3 The safest treatment option is ligation of the
fistula and creation of a new access site. Salvage is possible
by resection of the aneurysm followed by end-to-end anas-
tomosis, but this technique may require bypass in patients
with extensive or multiple aneurysms.4 Experience has
shown that bypass using a suitable autologous vein is reliable
but that prosthetic material gives disappointing results.5-
Recently, Balaz et al.6 proposed a new vein salvage tech-
nique consisting of venous aneurysmorrhaphy followed by
placement of an open-pore external support prosthesis
(ProVena, B. Braun Medical) to reinforce the wall of the
repaired vein. The purpose of this article is to describe our
experience with reinforced venous aneurysmorrhaphy to
treat VA complicating AVF.
Material and methods
Study population
Between August 2007 and May 2009, our vascular surgery
department performed 527 vascular access operations
including formation of new fistulas and revision surgery.
Demographic data, surgical technique and follow-up for all
patients were recorded prospectively in a computer data-
base. Informed consent was obtained from all patients for
their treatment.
For this study, the database was searched to identify all
patients operated on for VA complicating AVF. A VA was
defined as a circumscribed fusiform or saccular dilatation
having a threefold larger diameter than the vessel
segments immediately upstream and downstream from the
access site. A VA was considered as an indication for repair
if it was associated with one or more of the following:
 low flow due to aneurysm-related stenosis;
 erosion of overlying skin;
 short length of the cannulation route and:
B rapidly expanding aneurysm >2 cm per 6 months;
B pain in area overlying the aneurysm; and
B high flow associated with multiple aneurysms.
Preoperative assessment
Colour Doppler ultrasound (US) was performed to deter-
mine aneurysm length and diameter, detect intraluminalthrombus, identify stenoses and to measure flow. Ultraso-
nography of the vessels in the contralateral and ipsilateral
forearm and upper arm was also performed to evaluate the
feasibility of creating a new access site. If US demonstrated
impairment of fistula outflow due to central vein stenosis
involving the subclavian vein, brachiocephalic vein or
superior vena cava, diagnostic angiography was performed
to better assess the stenosis and patients were excluded
from this study. If the flow rate exceeded 1.5 l min1 or if
the patient presented with symptoms of heart failure,
echocardiography was performed.
Operative technique
All procedures were carried out under general anaesthesia
in an operating room by a vascular surgeon. All patients
received 1 g of cefuroxime intravenously. If the VA was near
or included the anastomosis, the upstream AVF anastomosis
was dissected first to allow control of incoming arterial
flow. Next, the arterialised vein was disconnected from the
artery and dissected with staged cutaneous incisions up to
the healthy non-aneurysmal zone (Fig. 1). In patients pre-
senting with extensive erosion of the overlying skin due to
repeated cannulation, wide resection of the redundant vein
wall and adjacent superficial tissues was preferred (Fig. 1)
to limit the extent of dissection and prevent local compli-
cations such as infection. The vein was then externalised
and a 6e8-mm-diameter atraumatic steel cannula was
introduced to allow calibration and location of the healthy
and aneurysmal segments. The aneurysms were resected
and venotomies were closed using a polypropylene longi-
tudinal running suture without causing stenosis (Fig. 2). In
cases of venous stenosis adjacent to the aneurysm, the
narrowing was resected with end-to-end anastomosis and
the aneurysm was treated as described above. Any
Figure 2 Aneurysmorrhaphy (arrow) and resection of venous
aneurysms after calibration of the lumen with the cannula.
Figure 4 The wrapped vein is tunnelized under healthy skin
and reanastomosed.
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procedure to ensure that the length of the healthy cannu-
lation route was greater than 10 cm. A saline-filled syringe
was used to rinse the vein and detect leakage. The repaired
vein was then scaffolded (Fig. 3) with a macroporous
polyester external prosthesis (6, 7 or 8 mm ProVena B.
Braun Medical) and tunnelled subcutaneously through an
undissected area to the previous anastomosis site (Fig. 4).
In most cases, a new side-to-end anastomosis was per-
formed and the exoprosthesis was attached to the artery
using a running suture through the mesh. In a few selected
cases involving radiocephalic fistula with high flow, the
proximal radial artery was ligated and end-to-end anasto-
mosis was performed between the repaired vein and distal
radial artery. After placement of a suction drain in
dissected areas, the wound was closed using a non-
absorbable 3/0 suture (Ethicon Inc., Somerville, NJ, USA).
The temporary placement of a jugular vein vascular access
catheter was necessary in most of the cases. Cannulation
was attempted for the first time 1 month after surgery. The
central vein catheter was removed after 10 consecutive
uneventful dialysis sessions.Figure 3 Polyester mesh wrapping around the vein; bulldog
clamp to control venous outflow.Postoperative follow-up
Clinical examination of the fistula was performed by the
surgeon before discharge from the hospital, after 1 month
and then every 6 months. Colour duplex US to assess
patency, measure flow through the vascular access and
evaluate the diameter of the repaired vein was performed
at 1, 6 and 12 months and yearly thereafter. In cases of
persistent high flow, the type of procedure used to reduce
flow and the postoperative flow rate measured were noted.
Endpoints and definition of success
The principal endpoint of this study was primary patency
after repair. Secondary endpoints included short-term
procedure-related complications, flow rates and diameter
of the repaired vessel. Patency at follow-up was defined as
less than 50% stenosis of the repaired vein lumen as docu-
mented by duplex US. The procedure was considered as
a technical success if the length of healthy cannulation
route after aneurysm removal was at least 10 cm and if the
patent vein was palpable immediately under the skin at the
end of the intervention. The procedure was considered as
a clinical success if the vascular access could be used for
routine twin-needle haemodialysis over a period of at least
1 month.
Statistical analysis
Statistical analysis was performed with StatView software
version 5 (SAS Institute, Inc., Cary, NC, USA). Nominal
variables were expressed as number and percentage of
patients. Continuous variables were expressed as mean and
standard deviation. The KaplaneMeier life table method
was used to calculate the primary patency curve.
Results
We identified 38 patients with VA complicating AVF during
the 20-month study period. Patients were referred to our
department either by the nephrologists at our institution or
Table 2 Type of vascular access, number of previous
accesses, and surgical indications.
Variable N (%)
Type of vascular access
Radial-cephalic fistula 17 (52%)
Brachial-cephalic fistula 12 (36%)
Brachial-basilic fistula 4(12%)




Indications to treatment VA
complicating AVF
Erosion of the overlaying skin 8 (24%)
Rapidly expanding aneurysm 5 (15%)
Pain overlaying the aneurysm 2 (6%)
Stenosis related to aneurysm 2 (6%)
High-flow with AFVA 16 (49%)
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patients in whom preoperative US revealed concomitant
central vein stenosis that was confirmed by angiography
were excluded from the study. The remaining 33 patients
were treated by reinforced venous aneurysmorrhaphy.
Vascular risk factors and underlying renal disease in these
33 patients are listed in Table 1. The types of vascular
access are listed in Table 2. The mean age of the AVFs at
the time of repair was 94 S.D. 75 months.
The diameter of the VA ranged from 2.5 to 6 cm. The
indications for VA repair are shown in Table 2. In six
patients, preoperative duplex US indicated that ligation
followed by creation of a new access on the contralateral
arm was feasible but this option was refused by the patients
either because it involved the dominant arm or because of
cosmetic considerations. Reconstruction of the AVF anas-
tomosis was required in 25 patients either because the VA
was included in the anastomosis (Mickley7 type I area) or
because the first segment of the arterialised vein was
diseased with altered flow on duplex US.
Details of operative techniques are shown in Table 3. In
15 cases, the diseased skin covering the aneurysm was
resected in a single block (Fig. 1) along with the redundant
vein wall. The diameter of the exoprosthesis was 8 mm in
10 cases, 7 mm in 12 cases and 6 mm in 11.
The procedure was a technical success in all patients.
Haematoma occurred prior to discharge in two patients,
including one requiring surgical evacuation. In another case
involving an 86-year-old diabetic patient, extensive
necrosis of the skin overlying the repaired vein occurred 1
month after surgery and resulted in exposure of the exo-
prosthesis. The fistula was ligated with removal of exograft
material. A prosthetic AV graft was implanted in the
contralateral arm. This case was considered to be a clinicalTable 1 Patient characteristics.
Variable NN (%) or mean SD
(range)
Age,y 55 S.D. 15 (14e86)
Male sex 24 (72%)
Diabetes 2 (6%)
Coronary artery disease 8 (24%)
Hypertension 21 (64%)
Hypercholesterolemia 6 (18%)
Tobacco use 5 (15%)
Past or present renal transplantation 24 (72%)
Other aneurysmal localization 4 (12%)
Underlying renal disease
Unknown 4 (12%)
Polycystic kidneys 5 (15%)
Immunoglobulin A nephropathy 2(6%)
Glommerulonephritides 1 (3)
Renal vascular disease 6 (18%)
Diabetes mellitus 1 (3)
Congenital nephropathy 6 (18%)
Nephronophthisis (Joubert syndrome) 1 (3)
Interstitial nephritis 4 (12%)
Vasculitis 3 (9%)failure. Swelling of the forearm with no effect on flow rate
was observed in one patient 5 months after surgery. Duplex
US revealed the presence of stenosis in an unreinforced
segment of the axillary vein. The patient was treated
successfully with percutaneous transluminal angioplasty
(PTA).
In the 16 patients with high flow in the access site, the
main reason for treatment was short cannulation route in
10 and a symptomatic cardiac failure with exertional
dyspnoea in six. Conventional side-to-end anastomosis was
performed in 14 patients. In the remaining two patients,
end-to-end anastomosis between the distal radial artery
and repaired vein was performed with ligation of the
proximal radial artery in the same procedure. In 10 of
the 14 in whom end-to-end anastomosis was performed,
the flow rate dropped below 1.2 l min1 (mean flow
reduction, 51%). In the remaining four patients, including
three with radialecephalic fistulas and one with a bra-
chialecephalic fistula, the reconstructed AVF was patent
but re-operation was necessary to correct the flow rate
that initially exceeded 3 l min1 and stayed above
1.5 l min1 after reinforced aneurysmorrhaphy. In the
three cases involving high flow in a radialecephalic fistula,
proximal radial artery ligation was performed after clinical
and duplex US evaluation demonstrated a patent ulnarTable 3 Technical details concerning the procedure and
hospitalization.
Variable Mean SD (range)
Duration of procedure (min) 156 S.D. 50 (70e255)
Number of aneurysms treated 2.2 S.D. 0.9 (1e4)
Length of skin incisions (cm) 25 S.D. 14 (12e53)
Length of covered vein, (cm) 22 S.D. 8 (8e47)
Diameter of exoprosthesis (mm) 6.9 S.D. 0.8 (6e8)
Duration of hospital stay (d) 4.5 S.D. 1.1 (2e7)
Figure 5 KaplaneMeier curve showing assisted primary
patency.
Months 0 6 12 18
N at Risk 33 31 22 8 
104 X. Berard et al.artery and palmar arch. Flow reduction was satisfactory in
two cases but one patient developed AVF occlusion 3 weeks
after re-operation and was considered to be a clinical
failure. In the case involving high flow in a brachiale
cephalic fistula, the patient had had four previous accesses
operations and had no further option. Moving the arterial
anastomosis distally was impossible because of poor-
quality forearm arteries but the first 4 cm of the exopros-
thesis were recalibrated to decrease the diameter from 8
to 4 mm. Following this experience, our current policy
when performing aneurysmorrhaphy in patients presenting
radialecephalic fistula with flow rates exceeding 3 l min1
consists of performing end-to-end anastomosis between
the arterialised repaired vein and distal radial artery with
ligation of the proximal radial artery when preoperative
duplex US scan and the Allen test document patency of the
palmar arch and ulnar artery. Application of this policy in
the two most recent cases has achieved an 80% reduction in
flow rate. Ligation of the radial artery was performed in
five patients (two intra-operative, three re-intervention)
with no alternative for creation of a new native vascular
access site.
During follow-up, US measurement showed that the
diameter of the scaffolded segment of the repaired vein
remained stable. It was 1 mm larger than the diameter of
the exoprosthesis even in the needling segment. No infec-
tion occurred.
Dialysis could not be performed during the study period
in 10 of the 33 patients in this series. These 10 patent AVFs
were considered as neither clinical successes nor failures.
Two of these 10 patients (operated on due to rupture risk)
were dialysed less than 1 month after revision because they
underwent kidney transplantation shortly after surgery. In
the remaining eight patients, VA revision surgery (indica-
tion: high-flow rate in six cases, stenosis in one case and
rapid expansion in one) was performed to maintain func-
tional access while their kidney transplant function wors-
ened, including three who required revision to normalise
flow rate in the repaired vein. In the remaining 23 patients,
dialysis was resumed. However, one occluded after revision
to correct high flow and one required removal of the AVF
because of skin necrosis. Both of these patients were
considered to be clinical failures. A total of 21 of the 23
patients were successfully dialysed. The mean time for
catheter removal was 57 days.
During the study period, no patient died or was lost to
follow-up (mean, 12 S.D. 5 months; range, 4e22 months).
Assisted primary patency was 93% at 6 and 12 months with
28 and 15, respectively, as the numbers at risk. The
KaplaneMeier patency curve is shown in Fig. 5.
Discussion
According to one meta-analysis including 34 studies,5 the
incidence of aneurysm and false aneurysm in haemodialysis
vascular accesses ranges from 0% to 6%. It is known that
grafts have a higher risk of aneurysm formation than fistulas
but the pathophysiology of VA in AVF is still unclear.8 Can-
nulation routes appear to be preferential locations for VA
due to repeated needling.3 Whenever possible, uncompli-
cated VA must be managed in accordance with DOQI
guidelines3 by abandoning the cannulation route in favourof a healthy segment. At our institution, uncomplicated
cases were managed conservatively by nephrologists and
these patients were not referred to us.
Another factor influencing the formation of VA as well as
management decisions involves downstream or upstream
stenosis, that is, pre-stenotic or post-stenotic aneurysm. In
pre-stenotic aneurysm, VA develops due to stenosis
located in the downstream vein. This type of dilatation is
caused by increased pressure in the arterialised vein.3 It
can be detected during dialysis sessions or suspected if
bleeding time is prolonged after cannula removal or if the
vein remains dilated in the elevated arm position. In this
series, two true hyperplasic stenoses located immediately
downstream from the VA were resected with end-to-end
anastomosis. With regard to downstream stenosis, it
should be mentioned that the treatment of choice for
central vein stenosis is PTA9 as in the five cases detected by
preoperative US in this study. Vesely et al.10 also reported
successful reduction of intra-graft pressure and blood flow
into the false aneurysm after angioplasty of central vein
lesions.
In post-stenotic aneurysm, increased turbulence induced
by upstream stenosis triggers VA formation in the post-
anastomotic venous segment.3,11 Surgery is recommended
over PTA for treatment of this type of stenosis.3 In this series,
duplex US usually demonstrated the presence of a highly
tortuous and/or calcified venous segment located either
upstream from the VA or between two VAs with altered flow.
The frequency of this finding and the high incidence of juxta-
anastomotic VA explains why reconstruction of the AVF
anastomosis was performed in 25 of the 33 cases in this
series.
In a large study, including 44 aneurysms involving both
AVF and grafts, Georgiadis et al.11 concluded that the
outcome of salvage surgery was better for AVF than grafts,
for true aneurysms than false aneurysms and for forearms
than upper arms. In the 26 patients with VA complicating
New Treatment for Aneurysmal Arteriovenous Fistula 105AVF, primary patency after salvage was 69% at 1 year.
Outcomes were also better using autogenous veins than
prostheses. Our 1-year patency rate was 93% even though
half of our patients had VA associated with high flow. In
another study involving patients with stenosed or throm-
bosed AVF, Georgiadis et al.12 demonstrated comparable
patency after interposition of either short polytetrafluoro-
ethylene (PTFE) segments (<6 cm) or autologous vein
grafts. Since VA tended to be extensive and multiple in our
series, autologous vein was preferred to long PTFE graft in
accordance with to DOQI guidelines.3
External reinforcement of vein grafts using external
prostheses has been reported previously. The first
description was by Parsonnet et al.13 in 1963. Melliere
et al.14 reported the use an exoprosthesis to reinforce
dilated saphenous vein segments in femoro-popliteal
bypass grafts. In a recent prospective multicentre study,15
promising short-term patency was obtained using ProV-
ena (B. Braun Medical) made from macroporous poly-
ethylene terephtalate to scaffold dilated or varicose vein
material after infrainguinal bypass. The first to describe the
use of Pro Vena for VA in haemodialysis patients with VA
was Balaz et al.6 who treated four patients but provided no
follow-up data.
Various partial resection techniques have been proposed
for the correction of VA. Lo et al.16 described simple
placation of the vessel using a running suture. This tech-
nique was used in a series of 15 cases but no information
was given concerning outcome with regard to either
patency or cannulation. Several authors17,18 have proposed
the use of a surgical stapler to reshape the VA. Pierce
et al.17 reported the use of staples in 12 patients, but
follow-up was less than 1 year in six patients and recurrent
aneurysm was observed in two. To avoid recurrence after
aneurysmorrhaphy, Grauhan et al.19 proposed wrapping
with a metal mesh. In their report, these authors made no
mention of cannulation problems but the presence of metal
(mesh or stapler) or of a thick plication could hinder
needling.
The use of the reinforced aneurysmorrhaphy technique
presents several potential problems. General anaesthesia
and a long surgical time are important limitations. As
observed in one elderly diabetic patient in our series, poor
wound healing may occur. In high-risk patients, endovas-
cular treatment or PTFE segment repair is preferable for
short VA and, if possible, creation of a new AVF is prefer-
able for extensive VA. Another concern in the use of
reinforced aneurysmorrhaphy involves VA associated with
a high-flow rate. Although the reduction of flow after
placement of the exoprosthesis in high-flow patients was
51% in this series, additional procedures were necessary in
four patients in whom pre-treatment flow exceeded
3 l min1. For VA associated with moderately high flow, we
recommend the use of a 6-mm exoprosthesis. In patients
presenting with VA associated with flow exceeding
2.5 l min1, reinforced aneurysmorrhaphy cannot normalise
flow; a more appropriate therapy for VA located in the
forearm is proximal radial artery ligation and end-to-end
anastomosis between the repaired arterialised vein and
the distal radial artery, if the ulnar artery is patent and
creation of a new AVF is impossible. In the upper arm, the
arterial inflow must be moved to forearm arteries.4 As instudies using other techniques, our follow-up was too short
to evaluate the effect of repeated needling through the
exoprosthesis on the repaired AVF and the possible risk of
recurrent aneurysm.
In conclusion, reinforcement using an external pros-
thesis is a safe and effective alternative for repair of
extensive VA. Further study will be needed to assess the
long-term patency rate, ascertain the risk of recurrence
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